Financial Partners Group, LLC Pfizer Inc Transaction History

Financial Partners Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $4,075 - $4,763	127 Added 0.1%	131,942 $4.38 Billion
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $196,167 - $226,961	-5,431 Reduced 3.96%	131,815 $4.83 Billion
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $4.85 Million - $6.32 Million	123,215 Added 878.16%	137,246 $5.6 Billion
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $585,794 - $764,689	14,031 New	14,031 $719 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Partners Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Partners Group, LLC with notifications on news.